This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Genetic Technologies Ltd (GENE)

NASDAQ: Services

Company Balance Sheet
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Assets
Cash and Equivalents 2.67M 1.79M 9.11M 5.46M
Receivables 1.05M 304.95K 507.93K 720.74K
Inventories n.a. 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 2.83K
Total Current Assets 4.11M 2.47M 10.19M 6.69M
Property, Plant & Equipment, Gross 5.06M 5.04M 6.37M 6.15M
Accumulated Depreciation & Depletion 4.69M 4.65M 5.71M 5.14M
Property, Plant & Equipment, Net 371.10K 392.66K 658.41K 1.01M
Intangibles 813.08K 919.71K 1.15M 1.50M
Other Non-Current Assets 748.99K 3.65M 4.52M 0.00
Total Non-Current Assets 2.23M 5.25M 6.65M 2.85M
Liabilities & Shareholder Equity
Total Assets 6.34M 7.72M 16.84M 9.54M
Accounts Payable 1.14M 927.94K 927.60K 1.19M
Short Term Debt 0.00 0.00 18.18K 72.54K
Other Current Liabilities 673.74K 713.28K 758.24K 725.88K
Total Current Liabilities 2.18M 2.29M 1.98M 2.16M
Long Term Debt 2.36M 0.00 0.00 0.00
Deferred Income Taxes n.a. 0.00 0.00 0.00
Other Non-Current Liabilities 76.52K 89.29K 111.16K 88.42K
Minority Interest -8.73K -47.43K -9.53K -9.26K
Total Non-Current Liabilities 2.43M 201.18K 269.51K 304.31K
Total Liabilities 4.61M 2.49M 2.25M 2.47M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 1.72M 5.23M 14.59M 7.07M
Common Par 84.81M 77.70M 85.29M 77.36M
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings -86.78M -76.13M -74.50M -72.10M
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 3.69M 3.67M 3.81M 1.81M
Total Capitalization 4.08M 5.23M 14.59M 7.07M
Total Equity 1.72M 5.23M 14.59M 7.07M
Total Liabilities & Stock Equity 6.34M 7.72M 16.84M 9.54M
Total Common Shares Outstanding 19.38M 15.85M 15.49M 13.49M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 19.15M 15.74M 15.35M 13.49M
Diluted Weighted Shares Outstanding 19.15M 15.74M 15.35M 13.49M
Number of Employees NA 64 64 58
Number of Part-Time Employees NA 0 0 0
GENE News

GENE Genetic Technologies Ltd

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 1 1
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GENE ANALYST REPORT

Brokerage Partners

GENE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs